CBD Forum by Chow420

Go back
Refer
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Study: Same-Day Cannabis Use Improves Sleep for Users With Anxiety

The relationship between cannabis and sleep is still widely debated. Research has found that cannabis can indeed help with sleep, and many consumers who use cannabis will also attest to its more sedative effects that combat symptoms like insomnia. One study even found that people are increasingly turning to cannabis instead of over-the-counter sleep aids. Conversely, other studies suggest the opposite, that cannabis use may impede sleep in some circumstances. Ultimately, it’s a complicated topic that seems to involve a number of variables, and like a bulk of cannabis research topics, our knowledge on cannabis and sleep is still growing. Though a recent study published in the journal Behavioral Sleep Medicine offers further proof that cannabis could help to improve sleep, specifically for consumers experiencing moderate anxiety who use cannabis the same day. Interestingly enough, anxiety and cannabis tends to be another contentious and complex topic. While cannabis is widely known to potentially increase anxiety and related symptoms, research suggests that — once again — this can be a complex topic involving a number of variables.  Specifically, THC is known to increase anxiety at high doses, while CBD and/or low-dose THC tends to help reduce anxiety. There are also individual factors, broadly how one person may respond to cannabis as it pertain to anxiety versus another, that can come into play. Researchers note the varied evidence for both sleep and anxiety in the study abstract, along with the various outcomes pertaining to specific cannabinoids. “Cannabis is increasingly used to self-treat anxiety and related sleep problems, without clear evidence of either supporting or refuting its anxiolytic or sleep aid effects,” researchers write. “In addition, different forms of cannabis and primary cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have differing pharmacological effects.” To investigate the relationship between cannabis use, anxiety and sleep quality, University of Colorado-Boulder researchers examined a cohort of 348 adults with mild-to-moderate generalized anxiety symptoms. Subjects were instructed to consume either cannabis flower or edibles dominant in THC, CBD or combined equal ratios of both THC and CBD. To follow the progression of each participant through the experiment, individuals in the study completed daily online surveys for 30 days. The study ultimately found that when participants reported cannabis use on a particular day, they also reported better sleep quality the following night. Researchers also noted that moderation analyses found better perceived sleep following cannabis use for respondents with higher baseline affective symptoms. The study also noted that respondents who used high-CBD edibles reported the highest perceived quality of sleep. Another recent study similarly examined how cannabis affects anxiety and sleep, looking to compare outcomes among patients prescribed cannabis-based medicinal products (CBMPs) for generalized anxiety disorder, both with and without impaired sleep. The research noted an association between CBMPs and improvements in anxiety, along with improvements in sleep and health-related quality of life. Similar to the CU Boulder study, those with the most severe baseline anxiety were most likely to experience the highest clinical improvements in anxiety upon the final 12-month assessment. A similar study from 2023 found that CBMP prescriptions were associated with “clinically significant improvements in anxiety.” The study also noted improvements in sleep quality and quality of life at 1-, 3- and 6-month time points. Looking more closely at cannabis and sleep, particularly same-day cannabis use, another recent study conclude that cannabis use is associated with “same day improvements in self-reported sleep quality, but not pain or depressive symptoms, although sleep improvements occurred in the context of increased frequency of cannabis use, raising the risk for cannabis use disorder.”

https://hightimes.com/

Jean-Michel Basquiat Remembered in Denim Collection

Iconic neo-Expressionist Jean-Michel Basquiat—whose work is among the most expensive American art of all time—is remembered in an inspiring collection of gear by Lee denim company, a denim jeans brand that dates back to 1889. Lee released a new collaboration on Feb. 6 that features the neo-Expressionist work of the late artist. Inspired by the street art scene of New York City, culminating in the early 1980s, the collection combines Basquiat’s creative vision, finding an inner child that’s often lost as we grow up. The Lee x Basquiat collection includes denim jeans, suiting pieces, sweaters, T-shirts and jackets. Some of the denim pieces don a print of Basquiat’s “Phooey” painting, a piece with commentary about consumption, property and the human condition. Another piece features Basquiat’s self-portrait “Warrior,” which shows how Basquiat saw himself in the art world. Another piece features the color scheme and bold stripes from Basquiat’s “Pez Dispenser.” The prices for the clothing starts at $65, which means they’re not designed for elitist art collectors—just everyday people. “Lee has always celebrated originality, and in our 100 years we’ve been part of American culture, especially the ‘80s around NYC,” said Brigid Stevens, global vice president of marketing for Lee. The Lee x Basquiat collaboration fuses art, style, and culture together to deliver pieces that are timeless and also unique—original icons made even more so with these iconic pieces of art.” In a matter of years, Basquiat went from being homeless and tagging SAMO (meaning same old shit, and it’s now copyrighted) to selling highbrow paintings fetching over 100 million dollars.  In May 2017, Basquiat’s painting of a skull, “Untitled,” sold for $110.5 million at Sotheby’s, and it was the highest price ever paid at auction for artwork by an American artist in a public sale at the time. The New York Times called its price tag “mind-blowing,” and curator Jeffrey Deitch said, “He’s now in the same league as Francis Bacon and Pablo Picasso.” Only Andy Warhol surpassed that, selling “Marilyn” for $195 million in 2022. Similar to the Expressionists of the late 19th century and early 20th century in Europe, neo-Expressionism was a total rejection of draftsmanship and realism, with a mish-mash of postmodern cultural, historical, nationalist, and erotic themes. Basquiat famously said that he couldn’t draw, and he said it often. It was his departure from societal norms that made his work so appealing. “This city is crawling with uptight, middle-class pseudos trying to look like the money they don’t have,” Basquiat told The Village Voice, which is often cited. “Status symbols. It cracks me up. It’s like they’re walking around with price tags stapled to their heads. People should live more spiritually, man. But we can’t stand on the sidewalk all day screaming at people to clean up their acts, so we write on walls.” While marketing a denim line was probably the last thing on Basquiat’s to-do list, it’s one way his family and estate can keep his name alive. He was also a major proponent of cannabis. Last April, High Times covered a recent Basquiat exhibition at The Grand LA, “King Pleasure.” When Basquiat was caught by smoking pot in his room at age 15, his dad unleashed a fury that drove him to run away and live on the streets. Multiple biographies indicate that Gérard Basquiat threw him out for smoking pot in his room.  Most of his days then were spent sleeping on benches in Washington Square Park in New York City. Once on the street, Basquiat experimented with other drugs such as LSD and heroin. Had he stuck with cannabis and natural drugs, he might be alive today. Gil Vazquez, executive director of the Keith Haring Foundation, told High Times about the relationship between Keith Haring, Basquiat, Fab 5 Freddy, and other artists in New York City’s street art scene at the time. “He really attracted like minded people and various kinds of energy,” Vazquez said.  In July 1988, Basquiat told Haring that he was facing the fact that he was addicted to heroin and had a problem—their only conversation on the matter. On August 12, 1988 in New York City, Basquiat overdosed on heroin. Unfortunately, being deceased in the world of art means the paintings are worth much more. Companies like Mellow Fellow have released vape carts themed after Basquiat paintings. The Basquiat, Blue Basquiat, and Basqui Gumbo strains are also named after him. Basquiat remains in the “Forever 27” squad of artists that includes Janis Joplin, Jimi Hendrix, Jim Morrison, and so on. But today one way you can remember him is through Lee’s collaboration.

https://hightimes.com/

One Dead in Fire at Los Angeles ‘Clandestine’ Cannabis Extraction Lab

One person was killed on Saturday morning and another is in critical condition after an explosion at a Los Angeles commercial building that housed what authorities say was a “clandestine” cannabis extraction operation. The fire and death, which occurred at a one-story commercial building in the Green Meadows neighborhood of L.A., is now being investigated by the Los Angeles Police Department and the Los Angeles Fire Department, according to multiple reports.  The LAFD responded to the fire after a 911 call to report the blaze was made at 1:17 a.m. on Saturday. As first responders arrived at the scene, heavy fire was visible at the seemingly vacant commercial building, and several small explosions could be heard within the structure, the LAFD reported on Saturday. The first firefighters to arrive on the scene forced entry onto the property and into a portion of the well-secured building to begin an offensive attack on the fire. The firefighters retreated, however, after facing “ever-increasing flames, a series of additional explosions, the presence of unknown chemicals and physical compromise of the structure, that rendered it untenable,” including a collapsed roof. The firefighters then transitioned to a defensive posture, using multiple hose streams of water from aerial ladders. As firefighters battled the blaze, a woman approached the command post that had been set up and reported her belief that a man was still inside the building that was at that point “largely consumed by flames.” “It took 113 LAFD responders under the command of Assistant Chief Douglas Lewis, 75 minutes to fully extinguish the inferno, confining fire damage to the structure of origin,” the LAFD noted. While searching the scene, fire department personnel discovered the body of what appeared to be an adult male deep within the smoldering remains of the building. Authorities also found a large volume of cannabis products, processing machinery, chemicals and pressurized gas cylinders.  A positive identification of the deceased person and the time and the cause of death are to be determined by the Los Angeles County Medical Examiner. The cause of the fire and circumstances surrounding the incident are being investigated by the LAFD and the LAPD. Although fired department officials originally reported no additional injuries as a result of the fire, LAPD Spokesperson Officer Jader Chaves said that a second person was transported to an area hospital in critical condition, according to a report from the Los Angeles Times. The nature and cause of the person’s injuries were not known, however. Chavez added that the operation housed by the building is being investigated as an “illegal butane honey oil clandestine lab.” Many cannabis operators use butane, propane or other hydrocarbons held by containers like those found in the burned-out building to produce cannabis extractions commonly known as butane hash oil, butane honey oil or BHO. The process can be hazardous if not executed carefully, and explosions and fires at such cannabis labs have occurred many times. Although cannabis is legal in California for both recreational and medicinal purposes, the state has a pervasive and thriving unlicensed marijuana production and processing economy. Authorities investigating Saturday’s fire believed the Green Meadows cannabis operation was part of this gray market. “We can’t say for sure because we don’t know exactly what permits they had…but we did not see any placarding from the outside that would indicate that this was a cannabis operation, which they should have had,” said LAFD Captain Adam Van Gerpen, according to a report on local television news. “There are multiple different types of chemicals that they use to do this and some of them could be explosive…and have deadly results.”

https://hightimes.com/

Ohio Legislators Still Working To Implement Changes to Adult-Use Cannabis Law

Ohio’s progress on cannabis has come to a temporary halt after House legislators fail to move the bill forward. Last week Ohio House Speaker Jason Stephens spoke to reporters, calling cannabis a “complex issue.” Voters approved Issue 2 at the ballot in November 2023, which took effect on Dec. 7, but since it was a citizen initiative, legislators have the power to add changes to the law after it has been approved by voters. Two bills, House Bill 86 and House Bill 354, would implement certain changes to the law established by the voter initiative, but legislators have not moved forward with either of them yet. House Bill 86 was initially introduced in February 2023, and would implement a few changes to the law established by Issue 2. HB-86 passed in the house between May and June 2023, and was introduced into the Senate in September. The Senate approved changes to the law by December, which includes automatic expungements and funding for the program, establishing a grace period for medical cannabis dispensaries to sell adult-use cannabis for 90 days after Dec. 7 (instead of nine months), expanding license eligibility, and funding the 988 suicide hotline. “In spite of the initial bills proposed by the House and Senate majorities which reduced the provisions in Issue 2 adopted by the people of Ohio, the Senate Democratic minority held the line and successfully negotiated a compromise bill that would salvage the voice of the people,” said Sen. Vernon Sykes in a press release in December. The Senate changes were sent to the House, which made no action to further the bill as of the session on Feb. 7. Despite any current or future changes, Issue 2 will still proceed as planned though. “Issue 2 puts in place a full regulatory framework … We don’t need the legislature to do anything,” explained Tom Haren, the spokesperson for the group behind Issue 2, Coalition to Regulate Marijuana Like Alcohol. Issue 2 also called for the creation of the Division of Cannabis Control (DCC) as part of the Ohio Department of Commerce, which will oversee the development of rules to regulate adult-use cannabis sales. According to the Ohio Capital Journal, the DCC is expected to have those rules in place by June 7. Provisional licenses will be given to non-medical cannabis facilities by Sept. 7, according to an email statement provided to the new outlet by Ohio Department of Commerce Public Information Officer Jamie Crawford.  The complexity that Stephens cited is due to two factors: first, setting up the process in how to determine who gets a dispensary license, and second, how to tackle tax revenue. “That’s where we are in our discussions and our priority right now is having those thorough discussions as there was a long runway for this issue, so we still have some time to do that,” said Stephens. When HB-86 was first introduced, the text focused on altering state liquor laws and not cannabis. If the bill’s changes were to be passed, it would establish a cannabis tax rate increase of 15% (Issue 2 set the tax rate at 10%). It would also allow city and county governments the ability establish their own additional taxes on top of a 3% excise tax. Home growing would be permitted for residents (up to six plants), and automatic expungements would be pursued for anyone who possessed 2.5 ounces of cannabis or less. If the bill makes it to Ohio Gov. Mike DeWine’s desk, all of these changes and more would take effect 90 days after the signing occurs. Additionally, HB-86 would distribute revenue funds to a variety of outlets, including county jail construction (28%), Department of Public Safety law enforcement training (19%), Attorney General law enforcement training (14%), substance abuse and treatment funds (11%), the 988 Suicide & Crisis Lifeline fund (9%), cannabis receipts drug law enforcement fund (5%), cannabis expungements fund (5%), safe driver training fund (5%), Ohio Investigative Unit Operations fund (4%), Division of Marijuana Control Operations fund (3%), and cannabis poison control fund (2%). While progress has ceased for now, some legislators are hopeful to see traction when the House resumes action on April 10. I think that everyone agrees that there are certain aspects of this legislation that weren’t adequately addressed in Issue 2, and we’ve talked about many different components,” said House Minority Leader Allison Russo. “I think there’s a lot of agreement on some things and then still many discussions that need to be had about other aspects.” Haren is also confident that progress will be made in just a few months. “It’s been unfortunate to see some members of the General Assembly so quickly try to subvert the will of the voters through House Bill 86, for instance,” said Haren. “But I’m encouraged the House is obviously taking a much more deliberate approach.” Separately, House Bill 354 was introduced last December as well, which aims to clarify Issue 2’s current language. While home cultivation would still be allowed, HB-354 specifies that growing must take place at a person’s home residence. It would also change the percentages of which agencies that cannabis tax revenue would be given to, including a community cannabis fund (36%), social equity fund and job fund (36%), substance abuse through the 988 Suicide & Crisis Lifeline fund (12.5%), additional substance abuse and addiction funds (10%), the Division of Marijuana Control and Department of Taxation (3%), and the Department of Mental Health and Addiction Services (2.5%).

https://hightimes.com/

New Study Shows Cannabis Extract Triggers Death of Melanoma Cells

A cannabis extract slowed the growth of skin cancer cells and triggered their self-destruction, according to the results of a recently published lab study. The study by Australian researchers found that a specific experimental Cannabis sativa extract known as PHEC-66 “might have potential as an adjuvant therapy in the treatment of malignant melanoma.” Melanoma only accounts for about 6% of all reported cases of skin cancer, according to a report from New Atlas. However, the aggressive form of the disease is so deadly that it causes more than 80% of skin cancer deaths. Melanoma shows a high resistance to traditional cancer treatments and is prone to metastasizing, or spreading to other parts of the body. Previous research has shown that compounds in cannabis might have antitumor effects related to the body’s endocannabinoid system. Studies show that the CB1 and CB2 cannabinoid receptors, which are found throughout the central nervous and peripheral immune systems, affect intracellular signaling pathways that control different biological processes such as gene transcription, cell motility, and the process of programmed cell death known as apoptosis.  The new study, which was published last month in the peer-reviewed journal Cells, tested the effects of PHEC-66 on the growth of primary and secondary (metastatic) human melanoma cells. The researchers found that the cannabis extract impeded the growth of the skin cancer cells by interacting with CB1 and CB2 receptors. The research also showed that PHEC-66 inhibited the progression of cell growth and division known as the cell cycle. Additionally, the cannabis extract influenced metabolic pathways by causing an accumulation of compounds in melanoma cells that can lead to apoptosis. “All these actions together start the process of apoptosis and slow down the growth of melanoma cells,” the researchers wrote. “The damage to the melanoma cell prevents it from dividing into new cells, and instead begins a programmed cell death, also known as apoptosis,” Nazim Nassar, a co-corresponding author on the study, said in a news report from Charles Darwin University. “This is a growing area of important research because we need to understand cannabis extracts as much as possible, especially their potential to function as anticancer agents. If we know how they react to cancer cells, particularly in the cause of cell death, we can refine treatment techniques to be more specific, responsive and effective.” The study shows that cannabis compounds could potentially be used to treat patients with melanoma. The researchers say the next step in the process is to develop methods to deliver PHEC-66 which would lead to pre-clinical trials to test the safety and effectiveness of the compound. “Advanced delivery systems still need to be fully developed, underscoring the importance of ongoing efforts to ensure the proper and effective use of these agents at target sites,” he said. Nassar noted that there is still a stigma associated with using cannabis compounds therapeutically. However, with continued research, the study’s findings have the potential to advance treatments for a wide range of medical conditions in addition to cancer. “Clinical uses of cannabis extracts include treatment for anxiety, cancer-related symptoms, epilepsy, and chronic pain,” said Nassar. “Intensive research into its potential for killing melanoma cells is only the start as we investigate how this knowledge can be applied to treating different types of cancers.” The team of scientists called for more research into the use of cannabis extracts including studies that showed the effect of cannabis compounds on skin cancer when combined with other treatments for the disease. “Further studies are required for a comprehensive understanding of its potential use in advanced-stage melanoma treatment, preferably involving more sophisticated models and assessing its viability within combination therapies,” they wrote.

https://hightimes.com/

Tripping? Nonprofit Launches New Psychedelic Info Hotline

Legal or not, people are experimenting with psychedelics, and they might as well be informed about their decisions in a logical manner, making situations safer. Colorado-based Unlimited Sciences, a psychedelic research nonprofit, unveiled the Psychedelic Info Line, a hotline that provides callers with data-driven education and informed resources for individuals considering exploring psychedelics. The core goal of the info line is to improve outcomes and reduce harm by offering the needed tools and information on natural psychedelics. The information provided isn’t just anecdotal evidence based on hearsay. Psychedelic Info Line navigators share knowledge from an extensive research library of peer-reviewed studies with data sourced from thousands of participants worldwide, including the world’s largest naturalistic psilocybin study sponsored and conducted by Unlimited Sciences.  Organizers say it provides a critical resource that no other organization provides. It offers informed answers to help people with their inquiries and make decisions before psychedelic use. “The Psychedelic Info Line represents the culmination of years of high-impact research and dedication to advancing our understanding of psychedelics,” said Matthew X. Lowe, PhD, Executive Director at Unlimited Sciences. “We hope the first one-on-one education line of this nature will have a positive impact in helping individuals make more informed decisions about safely using psychedelics.” In the past, the Cannabis Support Hotline was launched and provided by Unlimited Sciences’ parent nonprofit, Realm of Caring. The Psychedelic Info Line’s education specialists will not provide medical advice or encourage psychedelic consumption, rather they will foster a compassionate and supportive environment, striving to make every caller feel more capable in their quest for healing and self-discovery. Committed to community empowerment and safety, the Psychedelic Info Line is dedicated to educating and empowering the psychedelic community to navigate their journeys safely and responsibly. “We know psychedelics can be safe and deeply meaningful when those seeking to use them are well-informed and approach them with care. Providing a compassionate source of knowledge for people exploring psychedelics for healing and personal growth is our mission,” said Lynn Marie Morski, MD, JD, Director of Education at Unlimited Sciences. “By helping to distill and distribute evidence-based information, we give callers the knowledge and power to make informed and responsible decisions with their healthcare providers.” The Psychedelic Info Line is sponsored with support from The Wana Brands Foundation. Individuals who use the line and register through the Unlimited Sciences’ Client Portal receive access to exclusive educational resources including detailed guides on psychedelics, FAQs, and an extensive open-access research library.  People are encouraged to call toll-free 1 (888) 210-3553 (Monday through Thursday from 8:00 a.m. – 5:00 p.m. MST or email. Researchers are examining ways to avoid bad trips. Negative experiences with psychedelics were linked to stressful environments, a September 2023 study suggests. A study by researchers associated with Imperial College London indicated that stressful environments and other risk factors were associated with negative experiences with psychedelics, reaffirming the notion that “set and setting” play significant roles in positive experiences with psychedelic drugs. The study, which was recently published in the peer-reviewed journal Scientific Reports, gives new insight into the potential negative outcomes of using psychedelics in a clinical setting to treat serious mental health conditions. Study author Rebecka Bremler of Imperial College London’s Centre for Psychedelic Research told PsyPost that there was “a lack of research into this topic—at least when we started the project in 2021. There was (is) all of this amazing research on psychedelics’ positive effects on mental health, and some on acute challenging experiences (‘bad trips’) with psychedelics and what may contribute to them, but not so much on long-term negative psychological responses (which is what we focused on here).” “We wanted to find what may be potential risk factors for having these experiences, but also for people who had had them to be heard,” Bremler added. “The latter was one of the reasons why we included extended participants’ quotes in the article: to tell it in their own words as much as possible.” In the event of a bad psychedelic trip, you may be better off riding it through than taking additional drugs to extinguish the trip—which can actually be more dangerous. A recent study points out that psychonauts online are turning to benzodiazepines and other potentially dangerous drugs to end a psychedelic trip. Doctors are warning about so-called “trip-killers,” or drugs used to counteract the effects of a psychedelic trip. What they found is that over half of anecdotal recommendations online call for benzodiazepines, antipsychotics, alcohol, and other remedies, but found that trip-killers are often more dangerous than the psychedelics themselves.  The study, “Trip-killers: a concerning practice associated with psychedelic drug use,” was published in Emergency Medicine Journal on Dec. 19, 2023. It was announced in a news release the same day. Things like the aforementioned practices could be avoided if people have someone to talk to before choosing to experiment with psychedelics.

https://hightimes.com/

Report: Unlicensed Cannabis Grows Use More Water Than Licensed Grows in California

The University of California, Berkeley (UCB) recently published a scientific brief in February regarding illegal water use for cannabis plants. Entitled “Water Use: Cannabis in Context,” the brief was conducted by individuals at the Berkeley Cannabis Research Center, which is part of the College of Environmental Science Policy & Management. The Cannabis Research Center has been reviewing cannabis water use since 2017, and the most recent brief is split into four sections posed with a question. First, “How much water does cannabis use relative to stream flow?” explains that cannabis water use in regions along the Northern California coast and semi-inland areas (primarily Humboldt and Mendocino County) represents a “small fraction” of surface water supplies year-round, and especially during the months of July, August, and September. However, cannabis grows aren’t spread out evenly amongst these areas, with many farms gathered near one another. In those areas, “cannabis water demand represents >10% of available supplies during the dry season.” Researchers also make an important note that the watershed samples they refer to include demand mainly from unlicensed farms. The researcher’s second section addresses the comparison between water demand between unlicensed versus licensed farms. “Unlicensed cannabis accounts for significantly more cultivated area than licensed cannabis farming and therefore has a much larger water demand footprint,” researchers explained. “Furthermore, because unlicensed cannabis farms often have little to no water storage on-site, water is extracted from watersheds on demand, which tends to peak in August.” Ultimately, unlicensed farms consume much more than licensed farms throughout the year. “Water demand for unlicensed cultivation therefore exceeds that of licensed cultivation to an even greater extent in the driest time of year when stream flow is lowest,” the authors stated, recommending that incentives be provided for licensed farmers to be able to obtain or retain their existing licenses while “increasing off-site stream storage” to use as irrigation during the summer months. The third section explores how much residents in Humboldt and Mendocino Counties consume in comparison to the amount of water that licensed grows utilize. Researchers studied 91 watersheds and found that resident’s demand for water usage far exceeded that of licensed cultivators by 97%. “On average, licensed cannabis farm demands are one-tenth the amount of water as residential demand,” the brief states. “Water demands for other forms of agriculture in the region far exceed those of cannabis and residential use.” Finally, the last section examined water used licensed cannabis grows and found that those cultivation sites only used 4% or less of streamflow in the month of August, some even without additional water storage. “If licensed cannabis farms had enough water storage capacity to accommodate at least half of their annual water demand, there would be no watersheds among those sampled exceeding 2% of their estimated streamflow availability,” the authors concluded. “If licensed cannabis farms had storage capacity equivalent to their annual water demand, licensed cultivation would not require more than 1% of available flow in any sampled watershed.” The release of this brief is well-timed to educate voters as spring approaches, which is also when they will have the opportunity to choose, approve or reject the Humboldt Cannabis Reform Initiative (HCRI) which will appear as Measure A on the upcoming ballot. If approved, it would severely hinder local growers by banning them from making any changes to their farms. A report analyzing the HCRI was prepared for Humboldt County Board of Supervisors by the Humboldt County Planning Department in March 2023, explaining the harms of such a measure. “HCRI has been written to effectively discourage existing permit holders from modifying their permits in any way,” the report stated. “This includes adding infrastructure intended for environmental protections or modification of activities or site configuration to adapt to the evolving industry. These restrictions affect the smallest of farms permitted in Humboldt County to the largest cultivation sites.”  More recently, former Board of Supervisors member Mark Lovelace, who has spent the past seven years advising other California counties and cities on cannabis regulations, wrote an op-ed for Times Standard urging voters to vote no on Measure A. “Based on my professional analysis, I believe that Measure A will deal a devastating blow to the small cannabis businesses it purports to want to help,” Lovelace wrote. “The measure will impose an unrealistically small limit on the size of any new cannabis farms and will deny even the smallest ‘craft’ farmers any opportunity to grow or adapt their operations within Humboldt County. With cannabis prices continuing to fall, small farmers will be assured of making less money every year until they are no longer viable.” Lovelace described the measure as “grossly uninformed and demonstrates a deep lack of understanding of the cannabis industry and basic economics.” Measure A cites any grow larger than 10,000 square feet (which he describes as slightly larger than the average suburban lot), is a “large grow.” Additionally, the average size of all licensed Californian cultivator lots are more than 27,000 square feet, 93 cultivators are larger than 100,000 square feet, and nine include more than one million square feet. In addition to other important points of defense of local cannabis growers, Lovelace summarizes the effect that Measure A may have on small cultivators. “Measure A would put Humboldt County’s small cannabis farms at an extreme disadvantage against large growers elsewhere in the state, rendering them largely unviable in an increasingly competitive industry. I urge Humboldt County’s voters to vote NO on Measure A,” Lovelace concluded.

https://hightimes.com/

Man Dies at Tokyo Airport With Kilo of Drugs in His Stomach

An Israeli national has been reported dead at the Tokyo Airport as the result of an overdose after authorities said he tried to smuggle over a kilogram of cocaine and other stimulants in his stomach. According to an article in the Mainichi, a national daily newspaper in Japan, authorities with the Metropolitan Police Department filed charges with public prosecutors Wednesday, accusing a suspect in his 50’s, who was not named in the article, of violating the Stimulants Control Act by swallowing multiple wraps of illegal stimulants and getting on a flight from France to Japan with the intent of bringing the drugs into the country for distribution and sale.  The Mainichi said the deceased man collapsed inside the plane on January 2 as it arrived at the Tokyo Haneda Airport From France. He was taken to a hospital where he was later pronounced dead.  The suspect reportedly had 89 individual packets or wraps of cocaine and other stimulants. Medical staff told the Mainichi that none of the wraps burst, so it was unclear how the suspect succumbed to drug poisoning, but authorities with the Metropolitan Police Department’s narcotics and firearms control division surmised the drugs must have seeped out of the wraps somehow.  The process of smuggling drugs this way is referred to as “body packing.” A study on this practice by the National Institute of Health defined body packing as “the way of psychoactive substances smuggling by swallowing of carefully prepared packages with drugs into the gastrointestinal tract or by insertion them into the vagina or the rectum, especially in order to avoid finding them by the custom service.” During the study, researchers administered 60 wraps of cocaine totalling 500 grams to an otherwise healthy 29-year-old Polish male to monitor and observe how his body would react to the introduction of so many foreign objects. “During the 37-hours stay in our department the patient was monitored (blood pressure, heart rate, temperature), laxatives and oral fluids were administered. All the packages were evacuated through the natural way and it was followed up by the control abdominal radiography. No symptoms of acute cocaine intoxication or any other complications were observed,” the study said. Now you might be wondering, as I was while writing this, how exactly a person might go about smuggling drugs inside their body without ending up dead, as this man did. Well, some light internet digging netted me a few answers. A Vice profile on a Dutch cocaine smuggler illustrated how easy some believe this process to be. The girl, who was given the moniker Sharon, told Vice she began smuggling drugs from the small Caribbean island of Curacao to the Netherlands because of how common and easy it was in the area. “A lot of people would ask you to smuggle for them if they knew you were Dutch. But I always told them that I wouldn’t. Well, until I ran into a friend I knew from back home,” Sharon said to Vice. “She asked me if I would smuggle some stuff for her and I decided to do it. Everybody did it back then. Every flight would have at least ten or 20 people with drugs on it. Even little old grandmas were selling drugs in Curacao.” Packing the drugs is very important, as evidenced by the case at the Tokyo Airport, because if the packaging breaks it can cause overdose and death extremely quickly. Sharon told Vice that in her case, the cocaine was packed in plastic, wrapped in a latex glove then taped shut with a particular kind of packaging tape. Afterwards, additional layers of plastic and latex were added.  “It was really well packaged,” Sharon told Vice. “Some people had a hard time getting it down, though. They’d practice with a piece of carrot or something like that.”  Sharon also attested that she had a friend die at the age of 19 from a packaging burst. The kicker is Sharon was under the impression that she never took this risk, because she only ever swallowed boiled cocaine. I was unable to confirm if there was any accuracy to this information.   “That was pure coke, though. I only swallowed boiled coke, which won’t kill you. Or, at least, that’s what they told me,” Sharon said to Vice. “I’ve seen a lot of drug mules get dropped off at A&E [the emergency room], actually.” The test for whether packaging would hold up on its journey from esophagus to toilet bowl was simple, according to Sharon. She would simply drop it into a cup of water and if it sank to the bottom, it required repackaging. If it floated, down the hatch. “It’s not that complicated,” Sharon told Vice.

https://hightimes.com/

Houseplant Coffee Offers Non-Infused Roasts with Cometeer

On Feb. 5, Houseplant founders Seth Rogen, Evan Goldberg, and Michael Mohr announced that they collaborated with Cometeer to create a limited collection of coffee. Two roasts are currently available, including flavors named “Bean There Done That” and “Get Roasted.” The former is an Ethiopian medium roast that showcases sweeter flavors such as peach, sweet tea, and orange, which Cometeer describes as a shining example of the flavors that Ethiopian coffee is famous for. The latter is a Mexican dark roast that includes flavors such as dark chocolate, cashew, and baking spice, that creates a Mexican hot chocolate-like experience. These two coffee flavors aren’t cannabis infused, but Cometeer prides itself in its unique coffee-making process. The capsules can be melted in hot or cold water, and claims that “a freshly roasted, barista-quality cup of coffee is achievable in seconds.” Mohr said in a press release that Cometeer and Houseplant have a lot in common. “Houseplant exists to popularize a lifestyle that embraces contemporary cannabis culture by offering a breadth of products for people’s homes and daily lives. Alongside cannabis, very few products graduate to become a ritual and take an active role in creating memorable moments. As we acknowledge and celebrate all the ways that coffee enhances our own lives, Houseplant Coffee was a natural next step for us to bring to our customers,” Mohr said. “We couldn’t have chosen a better launch partner than Cometeer—we were thrilled to discover a team that brings such passion and innovation to coffee.” Goldberg also commented on how cannabis and coffee go hand-in-hand. “From where we sit, coffee and cannabis are the perfect pair,” Goldberg said. “Our first smoke of the day gets our creativity flowing and brings a sense of calm, while our morning coffee gives us energy and focus. Our goal with Houseplant Coffee by Cometeer is to provide that same sweet balance to both cannabis and caffeine enthusiasts alike. If they are one and the same, like us, all the better!” Even Cometeer CEO and co-founder Matt Roberts saw the connections between the two brands, although he didn’t mention cannabis consumption. “We were immediately drawn to Houseplant, another company focused on creating carefully developed, top-quality experiences at home,” said Roberts. “We easily found common ground testing and tasting with Seth and Evan, who quickly revealed themselves to be just as obsessed with coffee as we are, and landed on these two roasts that exceeded our high expectations. Now, we’re excited for Houseplant fans to experience the magic of Cometeer for the first time—a company focused on incredibly delicious coffee made impossibly convenient.” Rogen didn’t provide a comment in the press release, but did appear in a short social media video advertisement about the Houseplant x Cometeer collaboration. “At Houseplant we believe that before you bake, you must wake. And there’s no better way to wake than drinking coffee,” Rogen said. “And that’s why we partnered with Cometeer to bring you our favorite specialty coffees brewed for you, flash-frozen, to capture every molecule of delicious flavor,” he explained before taking a sip. “Houseplant coffee from Cometeer—it’s real fucking good.” Rogen also told The Hollywood Reporter how he and the Houseplant team love creating unique items. “With Houseplant, we always wanted to make a company where we can dive into the things that we were really personally passionate about and excited about beyond movies and television,” said Rogen. “It started with weed-based things, but we very quickly started selling records and vinyl. We very quickly found that we kind of built an infrastructure to just explore things that we generally loved and were excited by. And coffee is something that I drink all day, every single day. I drink a crazy amount of coffee.” Mohr chimed in, explaining that Rogen probably drinks anywhere between six to eight cups of coffee each day. For those who prefer to consume cannabis within their coffee, there are other brands out there. Willie’s Remedy, from musician Willie Nelson, makes CBD-infused K-Cups, as well as 250 mg CBD dark roast and medium roast coffee. The brand called House of Jane also offers a few CBD-based coffee, as well as delta-8 THC K-Cups as well. Brands like Strava offer multiple roasts, all infused with either 4 mg, 10 mg, or 20 mg hemp-derived CBD. High Times got an inside look at the up-and-coming CBD coffee and wellness brand, Lavender Coffee Boutique, last summer. Founder Lindsey Sozio explained the benefits of adding CBD to your daily routine. “I like the results of it. I just always thought since I started drinking it that, you know, I felt this calm focus, and I’m very productive on the days that I have CBD coffee. I’m like ready to go,” she told High Times. Lavender Coffee Boutique currently offers its own medium roast and dark roasts with or without CBD. Sozio explained her early plans to open a café for customers to enjoy coffee and promote wellness in their daily lives. “The goal of the store is to create an environment where people can come in who are curious about CBD, or they just want a really good cup of coffee,” she said. “So if you’re curious about CBD, and you want to come in, and it’s a high end luxurious space that you actually want to spend time in.” Sozio opened up the physical café at 1219 South Pearl St., in Denver, Colorado last November. The storefront now offers specialty coffee, baked goods, and also sells a variety of CBD wellness products to help customers promote health and calm in their daily lives.

https://hightimes.com/

From the Archives: A Tale of Bales (2019)

I arrived in New York City in 1976 to become an actor. But after five years of pounding the pavement and a moderate amount of success, I considered my odds and decided that stardom wasn’t in my stars. I landed in the fitness industry, which coincided with the fitness boom back when Jane Fonda was making videos and aerobic classes were the rage. I became the fitness director for New York Sports Clubs, a prominent chain of health clubs in the Northeast, and managed their exercise programs. But after eight years of professional exercise, I was cooked and profoundly unfulfilled. Aerobics? This is my life? As an actor, I’d waited tables on the Upper East Side and had become friends with a chef whom I worked alongside. His name was Peter Gorman, and he was an aspiring writer. Over time, his career had flourished. He ultimately was hired as an editor for High Times Magazine—which coincided with my disenchantment with the fitness industry. Gorman needed a photographer. He had been assigned to write a feature on the great Comanche war chief Quanah Parker, who gained fame as a fearsome warrior and, following his surrender, as a successful cattleman and leader of his people. Parker was also known as the founder of the Native American Church, which was formed in the aftermath of the so-called Indian wars and uses the sacred peyote cactus in its ceremonies. Gorman recommended me for the photography gig. So, in March of 1991,1 traveled to Oklahoma with him to do my first photo feature for High Times. I never looked back. A couple years later, I was hired as an editor as well. It certainly was never my ambition to become a top pot photographer but, as we all know, life takes us in unexpected directions. Truth be told, I’m not trained by any means. I didn’t even start taking photos until the age of 30. But I practiced like hell and always traveled with my camera. I shot people, rural scenes, cityscapes and still lifes, and I read articles about technique and studied what makes a successful shot in countless photography books. But taking thousands of photos prepared me for my career at High Times. Having photos published in a national magazine is a major thrill, one that’s never worn off for me. I realized early on that in order to have my shots published, I had to become a dual threat: a writer/photographer. From 1991 until I left High Times in 2017 as editor in chief, I became the most prolific contributor of writing and photography in the magazine’s history, traveling over a million miles on assignments. During most of my career, pot was downright dangerous. Everyone was paranoid—and with good reason. Growers and dealers were being busted daily, and punishment could be incredibly severe. But these were the people I depended upon to cover the world of marijuana. I remain amazed at their courage and beyond grateful for them welcoming me into their lives. No two people were more memorable or assisted me more than two Arizonans—Christie Bohling and Patrick Lange. I first encountered them at the inaugural meeting of the Hemp Industries Association, which took place in Paradise Valley, AZ, in late 1994. Christie and Patrick organized and spearheaded that conference. It’s crucial to understand that the early activists of the modern hemp movement, more often than not, had heavy dealings with pot. The cash that funded those first hemp companies and ventures was usually pot money. Christie had been a major-league smuggler in Arizona since the 1970s, the Queen Bee, a prime mover of thousands of pounds of Mexican marijuana. When she died in 2001, I wrote “The Ballad of Christie Bohling” for the magazine, a tribute in which I interviewed a number of her colleagues—even the Mexican “businessmen” themselves—who told tales of her sterling reputation. She was a classy outlaw: reliable, honest and, most important, able to turn huge shipments of pot into money. While Christie was brash and colorful, moving loads of pot with panache, showing the guys who the real boss was, Patrick was quiet and reserved, a man who rarely made eye contact—a cowboy type, taking things in, keeping judgments to himself. Patrick had met Christie in the 1980s, and his intricate knowledge of the back roads and dusty, barely there trails of the Arizona desert and hills had served them well. However, when I met them, Patrick was in the midst of a five-year stretch of probation, after being betrayed by a police informer. So, at least for the time being, the couple had shifted their focus to hemp. They cared deeply about the plant and both were students of America’s hidden hemp history. Together, they founded the Coalition of Hemp Activists (CHA), encouraging anyone who had interest in moving the issue forward to join them. The CHA even launched its own hemp clothing line. One of its crowning achievements occurred in 1992, when the CHA staged and funded a formidable protest at the San Antonio Drug Summit, renting its own convention hall right next to the antidrug confab, where six world presidents were in attendance. Three thousand members of the media were there, too—and were inundated with the real facts about hemp and marijuana. Christie, of course, was the outspoken one of the duo, giving frequent interviews and helping coordinate the infant hemp industry. Jack Herer, the arch activist and seminal leader of the movement who died in 2010, recognized her passion and welcomed her outspoken, take-no-prisoners approach to pot politics. Christie, in turn, asked Herer to attend the first Hemp Industries Association (HIA) conference, though he owned no actual company. Herer subsisted pretty much by selling his book at rallies, dealing pot and living very frugally. Christie wanted Herer’s towering presence at the conference to serve as a guiding, moral force as the HIA was formed. Christie’s swagger and outlaw poise had fascinated me. She was a raconteur who regaled everyone with tales of midnight desert transactions, escapes from law enforcement and stash houses overflowing with bales of Mexican weed. As much as Herer was the undisputed granddaddy of the legalization movement, he wasn’t on board with the HIA proceedings. Herer was adamant that the HIA’s mission statement include unequivocal support for legalization. He made no distinction between hemp and marijuana. If the DEA outlawed both, why should the activist movement favor one over the other? Those who disagreed with him believed that the HIA’s purpose was to function as a trade association, first and foremost, facilitating prosperity. Herer accused them of ignoring people behind bars serving time for marijuana “crimes.” I wrote the story about the conference, which was a huge hit. I also shot my first cover for High Times: Herer wearing his 100 percent hemp suit. The issue sold better than any other in over a decade. Herer had become an icon. At the HIA conference, Christie’s swagger and outlaw poise had fascinated me. She was a raconteur who regaled everyone with tales of midnight desert transactions, escapes from law enforcement and stash houses overflowing with bales of Mexican weed. I became friends with Christie and Patrick, and, over the years, they shared their connections, turning me on to a number of stories. They generously allowed me to use their home, located outside of Phoenix in the shadow of the San Tan Mountains, as my base of operations. Over time I realized that, occasionally, they would move a load of pot in order to fund their legitimate endeavors. I was never part of it, although I wanted to be. I wasn’t looking to be cut in on a deal, but I definitely wanted to photograph the load of weed. But Christie wasn’t having it. When I asked, she’d answer distantly: “Maybe some day…” But I never stopped asking. And then, during one visit in May 1996, she actually said yes. It was a Sunday afternoon and tripledigit temperatures had just arrived in the Arizona southland. I climbed into their pickup truck and then spent a few hours with them driving aimlessly from phone booth to phone booth, waiting for the okay to move in and grab the load. I had no idea how the transaction was supposed to occur, but I soon found out. About 3:30 in the afternoon, Christie and Patrick got the green light. We drove to the outskirts of Phoenix and pulled into a Circle K. Patrick got out and made another phone call, telling the connection that we’d arrived. This looked dubious. How do you transact a load of pot in the middle of the afternoon in a busy parking lot? About 15 minutes later, another car pulled in, driven by a fortyish Mexican dude. Patrick got out and walked over to the car. Christie said the driver had family on the other side of the border and they’d been smuggling weed for decades. I watched the conversation progress across the parking lot. The Mexican contact glanced over at me several times—not smiling. After a few minutes, he and Patrick shook hands and he drove off. Patrick walked back to us and said, “Okay. You can shoot the load, but you gotta drive it.” “Drive it?” I asked. “If you want to shoot it, you’re the one taking the risk.” “How big is it?” I asked. “One hundred pounds, in bales.” Now that’s a serious amount of pot. Having 100 pounds in my possession would be a big-time felony. Needless to say, transporting 100 pounds might be somewhat difficult to explain to a cop: “I’m just a journalist covering a story.” But a centerfold! For a High Times photographer, that’s the Holy Grail—a huge accomplishment in the world of weed. So I said, “OK, let’s do it.” Patrick handed me a set of car keys and pointed to a nondescript Dodge something or other that had been parked in the Circle K lot all along. “The weed’s in the trunk,” Pat said. “Now listen. We’re going to drive right behind you the whole way. Drive the speed limit, use your blinkers, put on your seat belt. If you get stopped for any reason, we’ll distract the cops.” “How?” I asked. “If you’re pulled over, we’ll drive like complete assholes. We’ll drive onto the shoulder and pass you and the cop on the inside. He’ll probably go after us and leave you alone. If that happens, just drive away slow. We’ll figure something out.” Now that’s a serious amount of pot. Having 100 pounds in my possession would be a big-time felony. Needless to say, transporting 100 pounds might be somewhat difficult to explain to a cop: “I’m just a journalist covering a story.” So we set out, driving through countless rural desert communities, with me operating the car as safely as a 16-year-old trying to pass his first driver’s license road test. About 130 miles later, Patrick passed me. Christie signaled me to follow as they drove by. A couple of minutes later, we pulled into the driveway of a typical Arizona ranch-style home—the stash house. The garage door instantly went up. I pulled the car in and the door closed just as quickly, courtesy of the stash house “manager.” Patrick opened the trunk of the car and pulled out black garbage bags filled with bricks of green Mexican sativa. I was ready. I’d already decided upon a concept. The next available issue was the annual “Travel” issue. I’d brought along a suitcase. We opened it up, stacked the bales and I went to work. The temperature stood at 114 degrees outdoors. Inside the garage, it was hotter. In no time, I was a sweaty mess. Stray buds and flakes of green seemed to attach themselves to my slick skin, like I was magnetized. After about 15 minutes, Christie got edgy, but I was immersed in the task. How often do you get to shoot something like this? “Did you get it yet?” Christie asked. “Yeah, I think so,” I said, but continued to shoot. Now, this was before digital cameras. Back then, when you shot on him, you never really knew what you’d get. So, naturally, I wanted to shoot 10 more rolls. I’d momentarily forgotten the risk that all of us were taking. But Christie was not someone to trifle with. She ended the shoot abruptly: “We’re done.” And so we were. I put my gear away and went inside the house to wipe the sweat off with wet paper towels and cool off in the AC. Christie and Patrick attended to business inside the garage. When I came back out, the load had disappeared. So had the car. We smoked a few souvenirs from the shoot and drove off—safely and with a lot less anxiety. As I’d hoped, the shot ran in the “Travel” issue with a big, boastful title: “Pack Your Bags.” Though pot legalization spreads across the land, I confess that I do miss the adventure and—yes!—the glamour of those early days. I miss the righteous outlaws. Those of us who didn’t grow or deal weed depended on these people for our stash. They were authentic heroes. Malcolm MacKinnon used the pen name “Dan Skye” during his tenure at High Times. Read the full issue here.

https://hightimes.com/

Empowering Choice

Every individual’s cannabis journey has a distinctive and often unforgettable beginning. For Sara Payan, her intricate relationship with cannabis bloomed during her inquisitive teenage years. Initially sparked by youthful curiosity, her engagement with the plant took on an intensely personal and transformative dimension in her 30s. Confronted with a diagnosis of stage-three colon cancer, Payan grappled with the dual challenges of the disease itself and the debilitating aftermath of chemotherapy. Cannabis became her safe place, alleviating the intense pain and overpowering nausea. That life-changing event led to Payan’s path towards cannabis education and advocacy.  With her podcast, Planted with Sara Payan, she’s featured a confluence of diverse voices including musicians David Crosby and Steven Van Zandt as well as policymakers like Rep. Earl Blumenauer. Her journey in the cannabis industry has included educating others about the benefits of the plant and advocating for patients on city and state advisory boards. Payan’s growing legacy hints at a promising future when cannabis is celebrated for its immense potential. Payan utilized medical cannabis in her cancer recovery and to combat the effects of chemotherapy, but her insights into the therapeutic potential of cannabis were not just borne out of personal experience. Her family background, especially her mother’s immersion in medical research as a cancer investigator and hematology oncology nurse, provided her with a unique perspective. This familial bond armed her with an early appreciation of the many benefits of cannabis, especially in managing debilitating symptoms. During Payan’s intensive cancer treatment, her interactions with dispensaries revealed a stark concern: the evident dearth of comprehensive consumer education. “I didn’t feel empowered in my choices,” she says. One particular incident, where inadequate guidance on edible consumption led to an overwhelming high during a medical consultation, was especially illuminating. These experiences, far from being isolated personal setbacks, underscored a broader challenge faced by people who turn to cannabis for its use as a medicine. As director of education and public education officer for the Apothecarium in San Francisco, California, Payan was able to focus on her mission to address the prevalent knowledge gap surrounding medicinal use of the plant. Alongside educational endeavors, she championed the principle of compassionate use and conceptualized and rolled out a pioneering program offering free cannabis to the critically and chronically ill, especially those from economically constrained backgrounds. While Payan’s contributions at the dispensary level were undeniably impactful, she recognized an overarching need for systemic reform. This realization propelled her into the arena of policymaking. “I decided to get involved in policy and I was one of the co-chairs for the legalization task force for San Francisco,” Payan says. But her advocacy didn’t end there. Representing medical cannabis patients, she emerged as a vital voice on the San Francisco Cannabis Oversight Committee and the California Cannabis Advisory Committee. “The biggest thing was helping city officials really take it seriously and understand that this is a viable industry, and all the amazing things that it can create for not only the people working in it but for the public,” Payan says. “We have a lot of work to do still.” As Payan’s commitment continued to grow, she found a fresh channel in her podcast, Planted with Sara Payan which began in 2019. The central ethos of Payan’s podcast is clear: to cultivate informed, open dialogues about cannabis. “We’re really talking about education, policy,” she says, spotlighting the need to challenge prevailing stigmas and outdated notions. Despite the advancements in legalization, misinformation, especially in mainstream media, remains a pressing concern for Payan. “A lot of the stuff coming out of the mainstream press isn’t necessarily correct,” she says. To counteract these skewed narratives, Payan has written for various publications ensuring that nuanced perspectives reach a wide audience. Down this line, she underscores the pivotal role journalists play in crafting narratives. “Responsible journalism is paramount in ensuring that the true essence of cannabis and its community is portrayed,” she says. Apart from her podcast, Payan has carved a niche as a respected consultant in the cannabis space. Her blend of personal experiences and professional acumen positions her uniquely, allowing her to provide invaluable insights. In her view, empathy in the cannabis industry is paramount and requires a consumer-centric approach rooted in understanding and compassion. This article was originally published in the November 2023 issue of High Times Magazine.

https://hightimes.com/

Weed Grown With Love Is Superior, And I Think I Can Prove It

The closest I’ve ever felt to God is on the back porch of a run-down house deep in the Humboldt Hills, smoking a sticky joint of last harvest’s In The Pines and watching the sunset after a long, sweaty day of trimming and pulling tarps. The euphoria of smoking that flower I helped grow and trim with my own two hands and infuse with love was unmatched. Now as a regular-ass person with a regular-ass job, I still seek out homegrown from friends, or farms that I know actually give a shit about their plants. It doesn’t matter the strain or growth method—although sungrown or light dep is always preferred—I just want flower that was cared for, looked after, played music to, stressed about, and protected from the elements with tarps at 2am when the storm hits. It simply makes me feel better—more in tune with myself, with nature, with the divinity of the universe. I’ve always felt in my bones that love-grown plants were superior to their counterparts grown like row crops purely for a profit, but until now, I couldn’t quantify “why” in a meaningful way. I knew it was better, because of how it made me feel, but I couldn’t prove it beyond anecdotal evidence. A vibe isn’t exactly a convincing argument, yet in a bizarre twist of fate, a vibe is exactly where this journey begins.  The basic concept of the law of vibration is that everything in the universe is in constant motion, and the speed of that motion can be measured in vibrational frequencies. From the chair you’re sitting on, to the thoughts you think, to even, yes, plants—everything in this universe emits a unique energy wave signature called a “vibrational frequency.” Humans emit vibrational frequencies based, in part, on the emotions they express, as illustrated in the Hawkins Map of Consciousness. Emotions like joy, peace, unconditional love, and acceptance are considered high vibrational frequencies, while emotions like fear, despair, jealousy, and anger vibrate at a much lower rate. As sentient beings, we can choose the thoughts we think and the emotions we feel, and therefore, can consciously alter our vibrational frequency to go either up or down.  We can also affect the vibrational frequencies of others, as well as be affected by others frequencies. Have you ever noticed how your mood changes when you’re around someone that emanates joy and gratitude? This phenomenon is literally just your frequency rising to meet theirs. The inverse is also true: being around a Debbie Downer can legitimately lower your vibration if you let her.  Plants are no different. They, however, cannot consciously alter their vibrational frequency. Meaning they are hyper-susceptible to the vibrational frequencies surrounding them, especially sound waves between 250-1000hz, which has been shown to increase plants yield, robustness, and tolerance to drought stress. Interestingly, these vibrational frequencies match the upper half of the Hawkins Scale, where emotional vibrational frequencies range from neutrality (250hz) in the middle, to enlightenment (700+hz) on the top end.  If it’s scientifically proven that plants can pick up and respond to our vibrations, and if the grower feels love (500hz) for his plants and joy (540hz) in tending to them, logically, wouldn’t the plants respond positively to those frequencies? To understand how deeply plants can feel our emotions and even our thoughts, we must discuss Cleve Backster. Backster was a polygraph and lie detector specialist with the CIA who, one night on a whim in 1966, hooked up his polygraph machine to the Dracaena in his office. Hoping to invoke some type of physiological response from the plant, he thought about burning one of the plant’s leaves, but was astonished to find that before he could act on the thought, the needle on the polygraph jumped in the same manner as a human experiencing a fright response. Backster repeated this experiment many times and became an international phenomenon, despite his findings being dismissed by academia.  Backster eventually formed a theory known as “primary perception” which postulates that a form of consciousness exists within all living things, even plants, and gives the ability to sense the thoughts and feelings of others.  If this is true, and plants are capable of mirroring frequencies, by design it would also prove that the frequency of the plant would affect the consumer. It has already been proven that consuming high vibrational foods like green, leafy vegetables, mushrooms, and seaweeds can raise vibrational frequency in humans. Is consuming cannabis any different? I think a large part of this equation has to do with the frequency the consumer is already operating at and the intention behind the consumption. If you’re habitually smoking to escape life and mindlessly play video games or doomscroll then you’re already operating at a low frequency, but if you’re smoking with the intention to expand your consciousness and pursue high vibrational activities like communing with nature or exploring your creative passions, then a high vibrational plant can alter the experience in a positive way, just as a low vibrational plant can diminish the experience in a negative way.  While the jury is still out on whether or not the absence of love negatively affects plants and lowers their status quo vibrational frequency, one thing is for certain: plants do, in fact, return the love they are given. And though we still don’t know the depths this rabbit hole reaches, it is safe to say plants which are nurtured, loved, and spoken to kindly make for a better consumption experience on many different levels—it’s science!

https://hightimes.com/

DEA Allows Big Pharma Giant that Helped Fuel Opioid Crisis To Continue Operating

The DEA has rescinded a 2023 directive which previously ordered a pharmaceutical company to shutter operations after they were found to have helped perpetuate the nationwide opioid crisis. Morris & Dickson, a multi-billion dollar Big Pharma giant which has been in business since 1841 will be permitted to continue selling drugs to Americans as per the result of a settlement reached with the DEA on Wednesday. This comes just under a year after the pharmaceutical wholesaler had their license revoked for continuing to produce and distribute suspicious shipments of controlled substances for years after a judge recommended their license be revoked for “cavalier disregard” of controlled substance laws. They also failed to report thousands of shipments of hydrocodone and oxycodone to the DEA.  “Of all the cases I handled as an administrative law judge for the DEA, Morris & Dickson’s violations were the most blatant and egregious,” Judge Charles Dorman told the Associated Press. “In addition, I saw no real acceptance of responsibility for their violations.” According to the DEA, Morris & Dickson will pay a $19 million fine and submit to heightened reporting requirements for five years as well as forfeit one of their two DEA Certificates of Registration, but they will be permitted to continue producing controlled substances from schedule two to five of the Controlled Substances Act. They also admitted all wrongdoing for their past actions. “Drug distributors like Morris & Dickson have a responsibility to protect the safety and health of customers and maintain effective controls against diversion of highly addictive controlled substances. At the height of the opioid crisis, Morris & Dickson failed to uphold that responsibility, and turned a blind eye as thousands of unusually large orders for hydrocodone and oxycodone went out the door,” said DEA spokesperson Katherine Pfaff. “Today, Morris & Dickson takes an important first step by admitting wrongdoing and paying for its misconduct, and today’s settlement will ensure that such irresponsible practices will not continue in the future.” Morris and Dickson’s legal wrongdoing came to light as the result of an Associated Press investigation in 2023 which not only found that the nation’s fourth largest drug distributor was playing it fast and loose with dangerous opioids, but also that the four-year delay in DEA action may have been the result of the so-to-speak “revolving door” between public entities and private companies which can lead to biased decision making at the government level. In the case of Morris and Dickson one such DEA employee, Louis Milione, spent 21 years working with the DEA in the Office of Diversion Control before retiring in 2017. After that, the Associated Press found that Milione became a consultant for the companies he was previously a regulator of, including Morris and Dickson, who hired him on a $3 million contract to essentially save their ability to produce and supply painkillers after the DEA accused the company of turning a blind eye to large suspicious orders of opioids.  Milione advocated for Morris & Dickson in court to little or no avail as the judge presiding over the case wrote a long scathing 159-page report recommending Morris and Dickson have their license revoked. According to the Associated Press, it was not until four years later when the AP asked the DEA to comment on their investigation into Morris and Dickson that the DEA finally followed through on what the judge recommended and revoked their license, only to reinstate it with this recent order less than a year later. “If the DEA had issued its order in a timely manner, one could then credibly believe that its second-in-command was not involved despite an obvious conflict of interest,” said Craig Holman, an ethics expert at the watchdog group Public Citizen in Washington to the Associated Press in 2023. “The mere fact that its action has been delayed four years just raises red flags. It casts the entire process under grave suspicion.” Morris & Dickson released a brief statement on their website regarding the DEA’s decision to reverse the original license revocation, choosing to give a very general thank you to the DEA rather than going into specifics about the case. “Morris & Dickson wants to thank the DEA for their recognition of our extensive efforts over the past five years to expand and improve our compliance system for suspicious order monitoring. We appreciate the DEA’s collaboration with us on our shared commitment to patient safety, and we are pleased that the DEA’s actions acknowledge both our current state-of-the-art compliance program and our commitment to continued enhancements into the future,” Morris & Dickson said.

https://hightimes.com/

Iowa Lawmakers Approve Bill To Regulate Consumable Hemp Products

An Iowa legislative panel this week approved a bill that sets limits on consumable hemp products sold in the state. The measure, House Study Bill 665, was approved on Wednesday by the House Public Safety Subcommittee by a vote of 2-0.  The bill, which was submitted to the state legislature by the Iowa Department of Public Safety (DPS), gives the state Department of Health and Human Services (HHS) the authority to regulate consumable hemp products. Under the measure, HHS can set cannabinoid potency limits on hemp products and set rules for their distribution and sale. The legislation also limits sales of consumable hemp products to adults aged 21 and older and sets criminal penalties for those who sell or give such products to minors. Hemp products were legalized federally by the 2018 Farm Bill, followed by the legalization of the crop in 2019 by the Iowa Hemp Act. But neither law sets quality standards for consumable hemp products or includes provisions to regulate their production, distribution and sale. The lack of regulation has led to a nationwide proliferation of hemp-derived products with intoxicating cannabinoids including Delta 8 and Delta 9 THC, among others. In Iowa, state lawmakers say they thought that such products were prohibited by the Farm Bill and the Iowa Hemp Act. “We thought we were dealing with the intoxicating aspect, only to find out that there are ways to get around that,” Rep. Steve Holt told The Gazette. “So it’s sort of the wild, wild west out there in a lot of ways, with THC-infused drinks being able to be served to minors, a lot of other things going on that are not acceptable.” Josie Wagler, the Department of Public Safety’s legislative liaison, said that the wide availability of intoxicating hemp products in Iowa made it necessary for the department to develop a regulatory proposal. “We’ve seen an emergence of high potency, high-THC products hit the market,” Wagler said. “And coupled with that, there are no age restrictions for purchasing these products. So really the purpose is to get at that, and to give HHS and law enforcement some additional tools to help regulate these highly intoxicating products.” The bill is supported by mental health advocates including Leslie Carpenter, the co-founder of Iowa Mental Health Advocacy, who told lawmakers that high-potency THC products pose the risk of serious mental consequences such as psychosis, especially when they are used by young people. “I fully support medical marijuana,” Carpenter said during a House subcommittee hearing on Wednesday, according to a report from Radio Iowa. “It’s the high potency THC products and that currently a child can walk into a store and purchase them that makes me very concerned.” Business owners in Iowa’s hemp industry oppose House Study Bill 665, saying the legislation goes too far. Scott Booher, the operator of Four Winds Farms, said that his business grows hemp for CBD and CBG, a cannabinoid that many people use to help with chronic pain, anxiety and sleep. He said he has many customers who buy these products for their children, but the bill advanced on Wednesday would make such use a criminal offense. “Let’s look at what needs to be taken care of instead of just sweeping everybody under the rug,” Booher told lawmakers at the hearing. “We have patients that are kids, we have parents that buy our hemp products for their children. For ADD, for behavioral problems.” Licensed hemp grower Tyson Allchin called out legislators for changing the standards regulating hemp and medical marijuana production. He believes he is the first Iowa grower to produce a hemp product that meets the standards for human consumption. “My flower was packaged and labeled as a food-grade ingredient, lessons on infusion and extraction for personal use had been planned out and promoted, and HHS approved it on January 31,” Allchin told Iowa Capitol Dispatch.  “And six days later, this bill attempts to ban it. I’ve exceeded state requirements, requirements which exceed federal guidelines,” Allchin added. “I’ve done everything required of me, and the state (is) continuously changing my goal. How can small farms ever get established when the state keeps moving our goal line?” Booher said that he agrees that some hemp producers are selling intoxicating products that are not in line with the spirit of hemp legalization laws. But the bill advanced by lawmakers on Wednesday conflates businesses like his that produce non-psychoactive products with bad actors in the industry. “Some of these people who are creating high THC products need to be held accountable in a different way,” Booher said, “maybe not with people who have low THC products.” Representative Phil Thompson said he appreciates that many people are “willing to admit there are bad actors” and that he understands the frustration of business owners who are following the rules in place. “But this is an important conversation to advance,” Thompson said. “I appreciate DPS on working on this and bring forth some guidelines on regulating this.” The legislation has now been referred to the full House Committee on Public Safety for further consideration.

https://hightimes.com/

Bernie Sanders Slams Big Pharma for ‘Ripping Off’ Americans with Highest Drug Prices

Tuesday, Sen. Bernie Sanders (I-Vermont) issued a report slamming the U.S. prices of drugs and executive pay of three major drug manufacturers—Johnson & Johnson (J&J), Merck, and Bristol Myers Squibb—just before a Feb. 8 hearing. Thursday the CEO’s of all three drug manufacturers had to appear before a hearing to be grilled by Sanders, prepared by staff associated with the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP Committee). The New York Times reports that they testified on their behalf Feb. 8, telling their side of the story. Americans, hands down, pay the most for life-saving drugs compared to other countries, the senator’s report summarized. In some cases, Americans are paying nearly 10 times the price as what Germans pay. Sanders’ detailed report outlines how the three companies are spending more on executive pay and stock buybacks than drug research and development (R&D). “The United States pays, by far, the highest prices in the world for prescription drugs,” the report reads, written by staff and headed by Sanders as Chair. “At a time when one out of four Americans cannot afford the medicine their doctors prescribe, ten large pharmaceutical companies made over $112 billion in profits in 2022 while paying their chief executives exorbitant compensation packages and spending billions of dollars on stock buybacks and dividends to make their wealthy stockholders even richer.” If you’re an American on the life-saving cancer drug Keytruda, you’re paying more than twice the amount that citizens in Germany—a highly industrialized nation—pay out of pocket. Merck began selling Keytruda in 2015 at an annual cost of $147,000 in the U.S. and $132,000 in Germany.  Keytruda now costs $89,000 annually in Germany, but $191,000 in the U.S. In Japan, Ketruda costs $44,000 annually, which is less than one-fourth of what Americans pay. The drug Eliquis, which prevents strokes, costs $770 annually in Germany but $7,100 in the U.S.—nearly 10 times as much. “The current industry business model is based on ripping off the American people,” the report reads. “For some of their most popular drugs, Johnson & Johnson, Merck, and Bristol Myers Squibb made more money in the U.S. than the rest of the world combined. The report includes a few key findings: In 2022, Johnson & Johnson made $17.9 billion in profits and its CEO received $27.6 million in compensation. J&J spent $17.8 billion that same year on stock buybacks, dividends, and executive compensation, compared to just $14.6 billion on R&D).  “In other words, the company spent $3.2 billion more enriching executives and stockholders than finding new cures,” the report reads.  In 2022, Bristol Myers Squibb made $6.3 billion in profits and its former CEO made $41.4 million in compensation. Bristol Myers Squibb spent $12.7 billion the same year on stock buybacks, dividends, and executive compensation, compared to just $9.5 billion on R&D. “Just like Johnson & Johnson, Bristol Myers Squibb spent $3.2 billion more enriching executives and stockholders than finding new cures,” the report reads.  In 2022, Merck made $14.5 billion in profits and its CEO made $52.5 million in compensation. That year, the company spent over $7 billion on dividends and executive compensation, and $13.6 billion on R&D.  “If Merck’s cancer drug Keytruda was its own company, its 2022 sales would rival McDonald’s annual revenue, and exceed the revenue of the hotel chain Marriott,” it reads. Senators have introduced bills to hold pharmaceutical drug companies accountable for pricing as well as other related practices. One angle to lower the cost of drugs has been bills that aim to reduce the cost incentive for pharmacy benefit managers (PBMs) to prioritize more expensive drugs because they receive higher payouts for higher priced drugs. In September 2023 Senate Finance Committee Chair Ron Wyden, (D-Oregon), and Ranking Member Mike Crapo, (R-Idaho) introduced the Modernizing and Ensuring PBM Accountability (MEPA) Act, a bill to brings more transparency, accountability and competition to pharmacy benefit manager practices in the pharmaceutical supply . Sen. Menendez (D-New Jersey), a senior member of the U.S. Senate Committee on Finance, said the Modernizing and Ensuring PBM Accountability (MEPA) Act includes his own inclusion, the Patients Before Middlemen (PBM) Act. HIV drugmaker Gilead Sciences was slammed for its PBM Express Scripts because it jacked up the prices of its lifesaving hepatitis C cures Sovaldi and Harvoni. But Gilead later changed its tune and joined a chorus of drugmakers—turning on PBMs. With the committee hearing Thursday, Sen. Bernie hopes to hold accountable the companies spending the least on drug development and the most on executive kickbacks.

https://hightimes.com/

Cannabeginners: What is Myrcene?

Found in both hops and cannabis, myrcene plays a huge role in the terpene profiles of the most popular cannabis cultivars and IPAs. Beyond contributing a funky, earthy, herbal aroma, this terpene has numerous well-documented medical benefits. Myrcene gets its name from Myrcia sphaerocarpa, a shrub from Brazil that contains lots of it and has long been used as a folk remedy for hypertension, diabetes, and diarrhea. Myrcene is a monoterpene, the smallest and simplest of the terpenes, and is found in high amounts in sweet basil, hops, mangos and cannabis. Myrcene is described as having an earthy, musky, herbal, clove-like aroma, but can be very pungent in higher concentrations, as in heavily hopped beers. Not surprisingly, hops and cannabis are both members of the family Cannabaceae. A 1997 Swiss study analyzed various cannabis cultivars for 16 terpenes and found myrcene to be the most abundant terpene out of those studied (others included pinene, limonene, carene, humulene, bergamotene, terpinolene, and caryophyllene). The myrcene content varied between 29.4% and 65.8% of the total terpenes depending on the cultivar. The next most abundant terpene, trans-caryophyllene, was just 3.8% to 37.5% of the total terpenes. While that study is nearly thirty years old, it is still widely cited and widely accepted as accurate.  One reason why myrcene could be so commonly found in cannabis is because some research suggests it could allow more absorption of cannabinoids across the blood-brain barrier (BBB). This effect of myrcene has been speculated about for years and long ago spawned a rumor that eating a ripe mango before smoking would get you higher. Despite a lot of hype about mangos and THC, research is very limited. Many sources online cite this study as evidence mangos get you higher, but when reading the study, the researchers are quite clear that “there is limited robust data supporting this claim,” and only have one source to support it. While a 2023 study notes, “myrcene’s potential to improve the transportation of delta-9-THC across the blood–brain barrier presents a promising avenue for developing centrally penetrant AD therapeutics;” unfortunately, the source cited to support that claim doesn’t mention myrcene and is actually focused on the flavonoid quercetin. Yet another study looking at cannabinoids and the BBB did not mention myrcene, indicative that it has no impact on the BBB.  So while the effects of myrcene on the BBB may be a topic of hot debate, let’s get into the medical effects of myrcene that we are more certain of. Myrcene has a range of reported medical properties, including “antipsychotic, antioxidant, analgesic, anti-inflammatory, sedative, muscle relaxant, and anticarcinogenic properties,” as well as anti-anxiety and anti-ageing effects. Over 30 years of research has shown myrcene has strong analgesic (pain relieving) and anti-inflammatory effects, both topically and internally, and suggested it be used for a new class of “aspirin-like drugs.” Over the years, hypotheses for these pain relieving effects have included the alpha 2-adrenoceptor (a major receptor for caffeine) and the TRPV1 capsaicin/vanilloid ion channel (involved in regulating pain and a receptor site for CBD). A 2022 study is the first to note that topical myrcene has “no synergistic effect with CBD.” Some of the earliest research on the analgesic effects of myrcene also showed it to be a sedative, which has only been supported by more recent research. In 2002, high doses of myrcene were found to potentiate the effects of the narcotic phenobarbital, as well as having powerful sedating and motor relaxant effects of its own. In a 2016 interview, cannabis researcher, Dr. Ethan Russo, noted that “sedation in most common Cannabis strains is attributable to their myrcene content, a monoterpene with a strongly sedative couch-lock effect.” In 2010, the National Toxicology Program found “equivocal evidence of carcinogenic activity of beta-myrcene,” meaning myrcene was shown to cause cancer. Five years later, The California EPA listed beta-myrcene as a cancer causing compound. While this 2020 study does note those potential cancerous effects of myrcene it also notes it could have anti-carcinogenic effects. One final piece of less-than-positive news about myrcene is that a 2023 study found it “was associated with statistically significant reductions in speed control and increased errors on a divided attention task.” This was the first study to look at myrcene’s impact on drivers and it appears to contribute to cannabis’ effects on driving-impairment.  In 2014, a team of French researchers were looking at hash samples from Morocco and discovered a totally new terpene, which they named hashishene. They also uncovered the mysterious origins of this terpene, that it was in fact a mutated form of myrcene, created by photo-oxidation, exposure to UV light and oxygen during the sun drying process. As hashishene is a mutant form of myrcene, it is also a monoterpene and has the exact same atoms in a different arrangement. Myrcene has been used as a folk remedy to treat a wide range of diseases, and this terpene has been heavily researched, showing many promising medical effects, though some potential risk of cancer. Despite some rumors about myrcene causing THC to have stronger psychoactive effects, research to support those claims is very limited. 

https://hightimes.com/

Product Review: Gard’nClean Liquid Ultra-Pure Chlorine Dioxide

We have all seen our fair share of products promising to revolutionize cannabis cultivation. But every so often, something comes along that genuinely deserves the hype. Enter Gard’nClean Liquid, an ultra-pure chlorine dioxide solution that’s turning heads in the cannabis community for all the right reasons. Let’s cut to the chase – growing cannabis isn’t a walk in the park. Between keeping your plants healthy and navigating the maze of industry regulations, cultivators have their work cut out for them. This is where Gard’nClean Liquid steps in, offering a practical and efficient solution to one of the biggest headaches in cultivation: Pathogens. Powdery Mildew, Botrytis, Aspergillus, Fusarium, and many other molds, bacteria, fungi, and viruses are the unseen enemies of any grower. They can ambush your crops, leading to reduced yields or in the worst-case scenario, total crop failure. Traditional methods of dealing with these bad boys often involve harsh chemicals that can do more harm than good to people, plants and equipment. Gard’nClean Liquid flips the script with its ultra-pure chlorine dioxide formulation, effectively tackling these pathogens without leaving harmful residues, damaging surfaces or irritating skin. Ensuring a comfortable and enjoyable experience for the user. But what does this mean for your plants? In my experience, using Gard’nClean Liquid can be a game-changer for improving environments. Reducing pathogen loads leads to increased overall plant health. Healthier plants mean better growth, less loss, and you guessed it, bigger yields. And let’s face it, at the end of the day, increasing yields is what counts.  As long as you can get it to market. One of the most impressive aspects of Gard’nClean Liquid is its ease of use. This isn’t some complex, high-tech gadgetry that requires a PhD to operate. It’s a straightforward, no-nonsense solution that integrates seamlessly into your existing cultivation routine. This ease of use is a big win, especially for cultivators who can’t afford to waste time or resources on complicated procedures. Now, let’s talk about compliance. The cannabis industry is under the microscope, with regulations that can be as tricky as growing the perfect strain. Gard’nClean shines here, too. Its ability to effectively eliminate pathogens means it helps growers not only meet but often exceed regulatory standards. This peace of mind is invaluable in an industry where compliance is as important as quality. User testimonials further solidify Gard’nClean’s reputation. Numerous cultivators report significant improvements in plant health and noticeable reductions in pathogen-related issues since incorporating Gard’nClean Liquid into their practices. These success stories are a testament to the product’s effectiveness and its potential to transform cultivation operations. To sum it up, Gard’nClean Liquid strikes me as the kind of product that comes from understanding the real-world challenges of cannabis cultivation. It addresses a critical need with a solution that is effective, safe, and user-friendly. Whether you’re a small-scale indoor grower or running a large commercial operation, Gard’nClean offers a practical approach to plant health and regulatory compliance. In the ever-evolving landscape of cannabis cultivation, staying ahead means embracing solutions that are innovative yet practical. Gard’nClean Liquid fits this bill perfectly. It’s not just solving problems – it’s enhancing the entire cultivation process. For cultivators aiming to optimize their environmental health and keep their plants thriving, Gard’nClean Liquid is definitely worth considering. In a market flooded with products and promises, Gard’nClean stands out as a true ally for growers.

https://hightimes.com/

Killer Mike Says Government Should Give Weed Industry to Black People

Killer Mike just made massive headlines when he was arrested and detained at the Grammys, but speaking out on this incident hasn’t been the only time he’s made the news in the past month. He also spoke up about the government giving the marijuana industry to Black people. Killer Mike was detained and subsequently released by the Los Angeles Police Department on the heels of his three wins at the 2024 Grammy Awards this past Sunday.  Mike, aka Michael Render, was handcuffed and escorted out by the police. Naturally, viral social media videos and coverage by The Hollywood Reporter came out right after the incident happened.  At the Grammys, Mike won for best rap song, best rap performance for “Scientists & Engineers,” and best rap album for Michael. The single features Andre 3000, Future, and Eryn Allen Kane. During his win, he gave a gracious speech about accepting his awards. “We are incredibly proud and are basking in this moment,” he says.  The LAPD initially only shared that Mike was arrested and booked for “misdemeanor battery” at the awards show, but then, more information started to come to light. According to Killer Mike, an “overzealous” security guard forced him into the altercation that happened after his wins.  “I do want to note that last night, my team and I fielded a number of calls from concerned fans and colleagues wanting to know if I was OK. As you can imagine, there was a lot going on, and there was some confusion around which door my team and I should enter,” he says in an official statement. “We experienced an overzealous security guard, but my team and I have the utmost confidence that I will ultimately be cleared of all wrongdoing.” A source in Killer Mike’s team adds: “We hit a speed bump in that Mike was detained and charged with a misdemeanor after collecting his awards. On the way into the venue, there was considerable confusion around where to go. He encountered an overzealous security guard and continued moving towards his destination. The situation has been overblown, but we are confident that the facts of the case, when laid bare, will show that Mike did not commit the alleged offense, and he will be exonerated.” The security guard claims she was injured by Mike at her assigned door entrance when she asked for his tickets and directed him to a security checkpoint. He then allegedly pushed past her, injuring her and causing her to call for help and alert the authorities. She signed a citizen’s arrest for misdemeanor battery, received medical treatment, and was photographed by law enforcement.  The Friday before the grammys, Killer Mike was already in the spotlight for his comments on HBO’s Real Time With Bill Maher. Always an outspoken activist for both Black rights and cannabis, Killer Mike was not shy with his statements. He claimed that if Black folks had control over the U.S. cannabis industry, racial equity would be better.  Mike says, “With Native Americans, we gave them the casino industry. What about, you know, supermarkets?”“Could Black people have the marijuana industry?” he adds. “Give us marijuana. Multibillion-dollar industry. It’s still fresh, it’s still growing.” These comments are not surprising given Killer Mike’s radical yet valid view that, while people of color largely contributed to the world of legal cannabis, they are still disproportionately being incarcerated while white people are getting rich and running million-dollar companies.  In the past, he has spoken out against inequality for Black people, and he avidly supported Bernie Sanders’ 2016 presidential campaign. He also hosted the Netflix show Trigger Warning with Killer Mike in 2019, a documentary series about issues facing Black people. He has also spoken about the Black community at rallies and protests.  With this history of activism and speaking up for Black folks, it is no surprise that he is scrutinizing the cannabis industry today. As the recent years highlight, cannabis is becoming more and more normalized, with most U.S. states at least legalizing medical cannabis, and CBD and THC both taking a more front-and-center role in community discourse. And it’s certainly true that if more people of color were in positions of power in the industry, there would be more equity.  Ironically, his first Grammy win since 2003, when he won best rap performance by a duo or a group for “The Whole World” is not tainted by an incident that paints him as a criminal. At the time, he called out, “Sweep! Atlanta, it’s a sweep!” This was for his work with Run the Jewels, a group he performed in alongside producer El-P.  It was a sweep once again, but not one without the very conflict that he speaks out against daily in his activism. Hopefully, he and his friends and family will still be able to enjoy the win. 

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.